Puma Biotechnology, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
5.08 | 36.09 | -85.94% | 41.17 | -87.67% |
| P/S |
|
0.67 | 127.4 | -99.48% |
|
|
| P/BV |
|
1.67 | 254.48 | -99.34% |
|
|
| P/FCF |
|
6.56 | -175.09 | -103.75% |
|
|
| Ev/Ebitda |
|
3.3 | -27.32 | -112.07% |
|
|
| Ev/S |
|
0.69 | 535.99 | -99.87% |
|
|
| Ev/FCF |
|
4.08 | -282.69 | -101.44% |
|
|
| E/P |
|
0.12 | 0.022 | 446.34% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
20.86 | -366.96 | -105.68% | 18.39 | +13.44% |
| ROE |
|
41.6 | 104.24 | -60.09% |
|
|
| ROA |
|
13.64 | -2.25 | -705.74% |
|
|
| ROIC |
|
-32.16 | 1.17 | -2839.49% |
|
|
| ROS |
|
13.14 | -291.95 | -104.5% |
|
|
| ROCE |
|
39.68 | 3.12 | 1173.06% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
7/10
|
1.54 | 0.98 | 57.46% | 2.48 | -37.96% |
| Nеt Debt/Ebitda |
|
0.1 | 1.06 | -90.42% |
|
|
| Debt/Ratio |
|
0.35 | 0.18 | 93.29% |
|
|
| Debt/Equity |
|
1.32 | 1.59 | -17.3% |
|
|
| Debt/Net Income |
|
2.45 | -1.45 | -268.48% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.53 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8 | -100% | ||
| DSI |
|
0 | 0.22 | -100% |
|
|
| Average dividend growth |
|
0 | 1.88 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.52 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.01 | -100% |
|
|
| Difference from average difference in sector |
|
-0.53 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
1/10
|
2.38 | -73.42 | -103.24% | ||
| Growth impulse Ebitda in 5 years |
|
-262.97 | -97.71 | 169.13% | ||
| Growth impulse Net Income in 5 years |
|
-150.46 | -85.91 | 75.14% | ||
| Growth impulse FCF in 5 years |
|
-302.41 | -91.82 | 229.35% | ||
| Growth impulse EPS in 5 years |
|
-140.57 | -75.92 | 85.16% |
IP Score
4.74/10
